Krystal Biotech, Inc.
Krystal Biotech, Inc. (KRYS) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 475 transactions totaling $238.0M, demonstrating a bearish sentiment with -$226.1M in net insider flow. The most recent transaction on Dec 5, 2025 involved a transaction of 5,000 shares valued at $0.
KRYS Insider Activity Summary
Who Is Buying KRYS Stock?
No significant insider buying has been recorded for KRYS in the recent period.
Who Is Selling KRYS Stock?
No significant insider selling has been recorded for KRYS in the recent period.
Is Krystal Biotech, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KRYS is bearish with an Insider Alignment Score of 2/100 and a net flow of -$226.1M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
KRYS Frequently Asked Questions
Understanding KRYS Insider Activity
Insider trading at Krystal Biotech, Inc. (KRYS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading KRYS stock, having executed 475 transactions in the past 90 days. The most active insider is Krish S. Krishnan (Executive), who has made 179 transactions totaling $100.1M.
Related Tools
Track Krystal Biotech, Inc. Insider Activity
Get notified when executives and directors at KRYS file new Form 4 transactions